Sweden
· Delayed Price · Currency is SEK Medimi AB Statistics
Total Valuation
Medimi AB has a market cap or net worth of SEK 5.61 million. The enterprise value is 5.34 million.
| Market Cap | 5.61M |
| Enterprise Value | 5.34M |
Important Dates
The next estimated earnings date is Monday, February 10, 2025.
| Earnings Date | Feb 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Medimi AB has 1.08 billion shares outstanding. The number of shares has increased by 90.25% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.08B |
| Shares Change (YoY) | +90.25% |
| Shares Change (QoQ) | -3.75% |
| Owned by Insiders (%) | 13.84% |
| Owned by Institutions (%) | 15.07% |
| Float | 915.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.64 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 1.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.40 |
| EV / Sales | 1.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.43 |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.61.
| Current Ratio | 2.33 |
| Quick Ratio | 1.44 |
| Debt / Equity | 0.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.24 |
| Interest Coverage | -31.23 |
Financial Efficiency
Return on equity (ROE) is -222.05% and return on invested capital (ROIC) is -107.96%.
| Return on Equity (ROE) | -222.05% |
| Return on Assets (ROA) | -73.48% |
| Return on Capital (ROIC) | -107.96% |
| Revenue Per Employee | 738,734 |
| Profits Per Employee | -2.22M |
| Employee Count | 6 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.49% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -86.49% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 42.14 |
| Average Volume (20 Days) | 2,573,043 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medimi AB had revenue of SEK 4.43 million and -13.33 million in losses. Loss per share was -0.01.
| Revenue | 4.43M |
| Gross Profit | 1.56M |
| Operating Income | -12.96M |
| Pretax Income | -13.33M |
| Net Income | -13.33M |
| EBITDA | -11.73M |
| EBIT | -12.96M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 3.27 million in cash and 3.00 million in debt, giving a net cash position of 269,000 or 0.00 per share.
| Cash & Cash Equivalents | 3.27M |
| Total Debt | 3.00M |
| Net Cash | 269,000 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 4.89M |
| Book Value Per Share | 0.00 |
| Working Capital | 4.67M |
Cash Flow
In the last 12 months, operating cash flow was -11.93 million and capital expenditures -536,507, giving a free cash flow of -12.47 million.
| Operating Cash Flow | -11.93M |
| Capital Expenditures | -536,507 |
| Free Cash Flow | -12.47M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | 35.29% |
| Operating Margin | -292.35% |
| Pretax Margin | -300.65% |
| Profit Margin | n/a |
| EBITDA Margin | -264.62% |
| EBIT Margin | -292.35% |
| FCF Margin | n/a |
Dividends & Yields
Medimi AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -90.25% |
| Shareholder Yield | -90.25% |
| Earnings Yield | -183.56% |
| FCF Yield | -222.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medimi AB has an Altman Z-Score of -5.81. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.81 |
| Piotroski F-Score | n/a |